Indivior Announces Participation in Key Investor Conferences

Author: Lucas Young Updated: 08-20-2025 12:12 PM

Indivior's Upcoming Investor Engagements

Indivior PLC (NASDAQ: INDV) is gearing up for key investor events that reflect its ongoing commitment to addressing the challenges of opioid use disorder (OUD). These events are crucial opportunities for investors to gain insights into Indivior's strategies, advancements, and overall market position.

Morgan Stanley Global Healthcare Conference

One of the prominent conferences Indivior will attend is the Morgan Stanley 23rd Annual Global Healthcare Conference, taking place in New York City. Joe Ciaffoni, the Chief Executive Officer, alongside Ryan Preblick, the Chief Financial Officer, will engage in one-on-one and group meetings on a significant date in early September. Joe will participate in a fireside discussion at 9:15 a.m. ET, allowing interested investors to delve deeper into the company’s vision and future prospects.

H.C. Wainwright Global Investment Conference

Following closely is the H.C. Wainwright 27th Annual Global Investment Conference, also set in New York City. In this venue, Joe Ciaffoni and Ryan Preblick will offer investors another chance to connect through personal meetings, providing a thorough overview of Indivior's initiatives and its role within the pharmaceutical landscape.

About Indivior

Indivior is a trailblazer in the pharmaceutical sector, dedicated to revolutionizing how opioid use disorder is treated. The company's vision is to ensure that all patients globally have access to evidence-based treatment for OUD. With a mission to redefine OUD from a crisis into a manageable chronic condition, Indivior is leveraging its established portfolio while expanding its pipeline of innovative treatments.

Headquartered in Richmond, VA, Indivior employs over 1,000 people worldwide, with its products available in over 30 nations, indicating a strong international presence. The company continues to invest in research and development to further enhance its product offerings aimed at helping those affected by OUD.

For more information about Indivior and its offerings, visit their website or connect with them on LinkedIn. The company’s proactive approach and strategic initiatives reflect a strong commitment to addressing one of the most pressing health challenges today, making it an interesting prospect for potential investors.

Frequently Asked Questions

What investor events is Indivior participating in?

Indivior is participating in the Morgan Stanley Global Healthcare Conference and the H.C. Wainwright Global Investment Conference.

Who are the key executives presenting at these events?

Joe Ciaffoni, the CEO, and Ryan Preblick, the CFO, will represent Indivior at these conferences.

What is the focus of Indivior's business?

Indivior focuses on developing treatments for opioid use disorder, aiming to change lives through effective medication solutions.

How large is Indivior's global presence?

Indivior's products are available in over 30 countries, and it employs more than 1,000 individuals worldwide.

Where is Indivior headquartered?

Indivior is headquartered in Richmond, Virginia, United States, emphasizing its established foundation in the industry.

About The Author

Even at just 28 years old, Lucas Young has made a name for himself as a writer and financial expert. Lucas is a gifted communicator of difficult financial ideas and has written a number of well-received books and articles that appeal to both new and experienced investors. The financial world has come to rely on his perceptive analysis and useful counsel. Many people have been enabled to make wise investment decisions by Lucas's commitment to financial literacy and his ability to demystify the complexities of the market. Lucas is still dedicated to advising and teaching people on their financial journeys as he shares his knowledge.

Contact Lucas Young privately here. Or send an email with ATTN: Lucas Young as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.